These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34596008)

  • 21. Clinical efficacy and safety of 4-hexyl-1,3-phenylenediol for improving skin hyperpigmentation.
    Won YK; Loy CJ; Randhawa M; Southall MD
    Arch Dermatol Res; 2014 Jul; 306(5):455-65. PubMed ID: 24402285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-hydroxycoumarin loaded vesicles for recombinant human tyrosinase inhibition in topical applications.
    Schlich M; Fornasier M; Nieddu M; Sinico C; Murgia S; Rescigno A
    Colloids Surf B Biointerfaces; 2018 Nov; 171():675-681. PubMed ID: 30107341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and in vivo evaluation of cationic elastic liposomes comprising highly skin-permeable growth factors combined with hyaluronic acid for enhanced diabetic wound-healing therapy.
    Choi JU; Lee SW; Pangeni R; Byun Y; Yoon IS; Park JW
    Acta Biomater; 2017 Jul; 57():197-215. PubMed ID: 28476587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.
    Shin H; Hong SD; Roh E; Jung SH; Cho WJ; Park SH; Yoon DY; Ko SM; Hwang BY; Hong JT; Heo TY; Han SB; Kim Y
    Br J Pharmacol; 2015 Jul; 172(13):3434-45. PubMed ID: 25766244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery.
    Xie J; Ji Y; Xue W; Ma D; Hu Y
    Colloids Surf B Biointerfaces; 2018 Dec; 172():323-329. PubMed ID: 30176512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of VEGF receptors in response to UVB promotes cell proliferation and melanogenesis of normal human melanocytes.
    Zhu JW; Ni YJ; Tong XY; Guo X; Wu XP
    Exp Cell Res; 2020 Feb; 387(2):111798. PubMed ID: 31874175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-(3,5-dimethylphenyl)-3-methoxybenzamide (A(3)B(5)) targets TRP-2 and inhibits melanogenesis and melanoma growth.
    Lee EJ; Lee YS; Hwang S; Kim S; Hwang JS; Kim TY
    J Invest Dermatol; 2011 Aug; 131(8):1701-9. PubMed ID: 21525883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent.
    Hamed SH; Sriwiriyanont P; deLong MA; Visscher MO; Wickett RR; Boissy RE
    J Cosmet Sci; 2006; 57(4):291-308. PubMed ID: 16957809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased therapeutic efficacy of a newly synthesized tyrosinase inhibitor by solid lipid nanoparticles in the topical treatment of hyperpigmentation.
    Al-Amin M; Cao J; Naeem M; Banna H; Kim MS; Jung Y; Chung HY; Moon HR; Yoo JW
    Drug Des Devel Ther; 2016; 10():3947-3957. PubMed ID: 27980392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationalizing the Design of Hyaluronic Acid-Decorated Liposomes for Targeting Epidermal Layers: A Combination of Molecular Dynamics and Experimental Evidence.
    Franzé S; Rama F; Rocco P; Debernardi M; Bincoletto V; Arpicco S; Cilurzo F
    Mol Pharm; 2021 Nov; 18(11):3979-3989. PubMed ID: 34570510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.
    Lim YJ; Lee EH; Kang TH; Ha SK; Oh MS; Kim SM; Yoon TJ; Kang C; Park JH; Kim SY
    Arch Pharm Res; 2009 Mar; 32(3):367-73. PubMed ID: 19387580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tranexamic Acid-Encapsulating Thermosensitive Liposomes for Site-Specific Pharmaco-Laser Therapy of Port Wine Stains.
    van Raath MI; Weijer R; Nguyen GH; Choi B; de Kroon AI; Heger M
    J Biomed Nanotechnol; 2016 Aug; 12(8):1617-40. PubMed ID: 29342342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of urea-extracted sericin on melanogenesis: potential applications in post-inflammatory hyperpigmentation.
    Aramwit P; Luplertlop N; Kanjanapruthipong T; Ampawong S
    Biol Res; 2018 Nov; 51(1):54. PubMed ID: 30497518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing Tranexamic Acid Penetration through AQP-3 Protein Triggering via ZIF-8 Encapsulation for Melasma and Rosacea Therapy.
    Tang J; Li Y; Hu X; Hua W; Xu H; Li L; Xu F
    Adv Healthc Mater; 2024 Jul; 13(17):e2304189. PubMed ID: 38539056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of vehicle-nanoparticle interactions in topical drug delivery.
    Moddaresi M; Brown MB; Zhao Y; Tamburic S; Jones SA
    Int J Pharm; 2010 Nov; 400(1-2):176-82. PubMed ID: 20727392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Chemically Modified Curcumin (CMC) Derivatives Inhibit Tyrosinase Activity and Melanin Synthesis in B16F10 Mouse Melanoma Cells.
    Goenka S; Johnson F; Simon SR
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33946371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis.
    Shrotriya S; Ranpise N; Satpute P; Vidhate B
    Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1471-1482. PubMed ID: 28884598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin permeation and retention of topical bead formulation containing tranexamic acid.
    Vijayakumar A; Baskaran R; Yoo BK
    J Cosmet Laser Ther; 2017 Feb; 19(1):68-74. PubMed ID: 27762649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
    Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.